Literature DB >> 8077694

Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells.

N T Sepp1, L J Li, K H Lee, E J Brown, S W Caughman, T J Lawley, R A Swerlick.   

Abstract

Modulation of the expression of the alpha v beta 3 complex on human dermal microvascular endothelial cells (HDMEC) may be crucial in wound healing and angiogenesis. Therefore, we examined the influence of basic fibroblast growth factor (bFGF), transforming growth factor beta, and interferon-gamma (IFN-gamma) on the expression of this complex. Stimulation of HDMEC with bFGF increased cell surface expression of both alpha v and beta 3 in a dose- and time-dependent manner associated with the development of a spindled, elongated cell morphology. Northern blot analysis of HDMEC stimulated with bFGF demonstrated a marked increase in beta 3 but not alpha v mRNA expression. Incubation of HDMEC with transforming growth factor-beta or interferon-gamma alone resulted in modest decreases in cell surface alpha v beta 3, and co-incubation of HDMEC with bFGF and transforming growth factor-beta or interferon-gamma inhibited bFGF-induced changes in cell morphology, increases in cell surface alpha v beta 3 expression, and increases in beta 3 mRNA. These data demonstrate that both growth factors and pro-inflammatory cytokines alter the expression of alpha v beta 3 on microvascular endothelial cells and that these alterations correlate with changes in cell morphology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077694     DOI: 10.1111/1523-1747.ep12394617

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

1.  Adenovirus-mediated expression of tissue plasminogen activator does not alter endothelial cell proliferation and invasion.

Authors:  D K Zablocki; J J Rade; B R Alevriadou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

2.  Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.

Authors:  I N Gavrilovskaya; E J Brown; M H Ginsberg; E R Mackow
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Cross talk between beta(1) and alpha(V) integrins: beta(1) affects beta(3) mRNA stability.

Authors:  S F Retta; G Cassarà; M D'Amato; R Alessandro; M Pellegrino; S Degani; G De Leo; L Silengo; G Tarone
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

Review 4.  Interferons as antiangiogenic agents.

Authors:  Daniel J Lindner
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

5.  Structure and function of a vimentin-associated matrix adhesion in endothelial cells.

Authors:  M Gonzales; B Weksler; D Tsuruta; R D Goldman; K J Yoon; S B Hopkinson; F W Flitney; J C Jones
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

6.  Effects of macrophage metalloelastase on the basic fibroblast growth factor expression and tumor angiogenesis in murine colon cancer.

Authors:  Zhangwei Xu; Hai Shi; Qiao Mei; Yuxian Shen; Jianming Xu
Journal:  Dig Dis Sci       Date:  2011-08-04       Impact factor: 3.199

Review 7.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 8.  The role of alphav integrins during angiogenesis.

Authors:  B P Eliceiri; D A Cheresh
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

9.  Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.

Authors:  D R Senger
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 10.  Role of the beta3 integrin subunit in human primary melanoma progression: multifunctional activities associated with alpha(v)beta3 integrin expression.

Authors:  R E Seftor
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.